Jack Kaye

CIK 1376099 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$618.9K

Companies

3

Total Filings

48

Lifetime Open-Market Net

-$1.89M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QURE Director 20,439 $27.57 $563.5K -$1.69M 21 2026-06-05
DYAI Director 81,201 $0.68 $55.4K $0 10 2026-01-06
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 86,400 -$195.8K 17 2015-06-18

Recent Filings · Page 2 of 5

48 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-04 DYAI Mixed +27,174 $0 EDGAR
2023-06-20 QURE Mixed +6,420 -$43.2K EDGAR
2023-03-01 QURE Sell (S) −384 -$7.7K EDGAR
2023-01-05 DYAI Grant (A) $0 EDGAR
2022-06-17 QURE Grant (A) +9,080 $0 EDGAR
2022-06-14 DYAI Grant (A) $0 EDGAR
2022-03-02 QURE Sell (S) −600 -$10.1K EDGAR
2022-02-28 QURE Grant (A) +1,534 $0 EDGAR
2022-01-05 DYAI Grant (A) $0 EDGAR
2021-03-04 QURE Sell (S) −504 -$19.0K EDGAR
Showing 1120 of 48
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.